This difference also existed when the GluN1/α7 ratio pulled-down was normalized to total GluN1 in the homogenates, thus taking the lower GluN1 expression in the AD lysates compared to the non-AD control lysates into account (Fig 2F). The gene discussed is GRIN1; the disease is Alzheimer disease.